Douglas R. Fullen - Concepedia

Author

Douglas R. Fullen

Also Known As

D Fullen, D. Fullen, D. R. Fullen, D.R. Fullen, DOUGLAS R. FULLEN, Douglas Fullen, Douglas R Fullen, Douglas R. Fullen, Douglas Randall Fullen, McHugh, Jonathan B.

225

Publications

8.8K

Citations

H-Index

Concepts

All Affiliations

University of Michigan Michigan Medicine Michigan Center for Translational Pathology Howard Hughes Medical Institute Henry Ford Health System

About

Douglas R. Fullen is an author at University of Michigan specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	46	5.7K
2	Health Sciences	3	3	321
3	Allergy	2	2	35
4	Anatomy	2	2	23
5	Natural Sciences	1	1	11

Douglas R. Fullen

Publications

8.4K

Citations

H-Index

Page 1

	Year	Citations
Efficient tumour formation by single human melanoma cells Elsa Quintana, Mark Shackleton, Michael S. Sabel, Nature Efficient Tumour FormationMelanomaTumor TargetingMedicineCell Biology	2008	1.8K
Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized Elsa Quintana, Mark Shackleton, Hannah R. Foster, Cancer Cell Hierarchically OrganizedTumor HeterogeneityMedicineMelanomaPathology	2010	595
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma Nallasivam Palanisamy, Bushra Ateeq, Shanker Kalyana‐Sundaram, Nature Medicine Systems BiologyMedicineReceptor Tyrosine KinaseGastric CancerTumor Suppressor	2010	468
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway Christophe Denoyelle, George A. Abou-Rjaily, Vladimir Bezrookove, Nature Cell Biology Signal TransductionSignaling PathwayCell RegulationAnti-oncogenic RoleReceptor Tyrosine Kinase	2006	333
The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma Paul W. Harms, Pankaj Vats, Monique Verhaegen, Cancer Research	2015	327
BRAF and NRAS mutations in melanoma and melanocytic nevi Jenny N. Poynter, James T. Elder, Douglas R. Fullen, Melanoma Research	2006	237
Risk Assessment for Atypical Spitzoid Melanocytic Neoplasms Using FISH to Identify Chromosomal Copy Number Aberrations Pedram Gerami, Richard A. Scolyer, Xiaowei Xu, The American Journal of Surgical Pathology CytogeneticsGeneticsPathologyConventional MelanomaGenomics	2013	197
The atypical Spitz tumor of uncertain biologic potential Mathew W. Ludgate, Douglas R. Fullen, Julia Lee, Cancer	2009	195
Histomorphologic Assessment and Interobserver Diagnostic Reproducibility of Atypical Spitzoid Melanocytic Neoplasms With Long-term Follow-up Pedram Gerami, Klaus J. Busam, Alistair J. Cochran, The American Journal of Surgical Pathology Clinical BehaviorDiagnosisPathologyConventional MelanomaDermatology	2014	172
Transcriptome Profiling Identifies HMGA2 as a Biomarker of Melanoma Progression and Prognosis Leon Raskin, Douglas R. Fullen, Thomas J. Giordano, Journal of Investigative Dermatology MedicineMelanomaPathologyMelanoma ProgressionCancer Genomics	2013	163

Page 1